KL Acquisition today in a filing registered its planned IPO of 25 million units priced at $10 each.
With a focus on the healthcare sector, the SPAC said, “Our strategy will be to identify, acquire and, after our initial business combination, build a healthcare or health-related business. We intend to focus our investment effort on life sciences, which includes medical devices, diagnostics and life sciences tools and instrumentation.”
KL Acquisition plans to list on the Nasdaq under KLAQU. Read more.
KL Acquisition Files for $250M IPO
